Table 16.
Country | Year of samplinga | Seroprevalence (%)b | Number of samples tested (n)b | Methodc | Reference |
---|---|---|---|---|---|
Pet cats | |||||
Argentina | 1993 | 20 | 169 | IHAT | [598] |
Brazil | 1996–97 | 18 | 248 | IFAT | [599] |
Chile | < 1992 | 40 | 65 | IHAT | [600] |
France | < 1997 | 43 | 519 | IFAT | [401] |
< 1998 | 43 | 506 | IFAT | [561] | |
Germany | 1989–90 | 46 | 231 | IFAT | [601] |
1989–90 | 31–47** | 218* | ELISA | [602] | |
1989–90 | 34–51** | 218* | IFAT | [602] | |
1992–94 | 34–61** | 465* | ELISA | [603] | |
Italy | 1996 | 9 | 113 | IFAT | [564] |
Japan | 1994–95 | 9 | 471 | LAT | [604] |
< 1998 | 6 | 800 | LAT | [605] | |
Mexico | < 1999 | 71 | 24 | ELISA | [606] |
Singapore | < 1992 | 7 | 15 | LAT | [607] |
Sweden | 1986–87 | 42 | 241 | ELISA | [542] |
Taiwan | < 1990 | 8 | 117 | ELISA | [608] |
Turkey | 1994 | 43 | 65 | SFDT | [609] |
USA (Oklahoma) | 1987–88 | 22 | 618 | LAT | [610] |
Stray or feral cats | |||||
Australia | < 1997 | 50 | 18 | LAT | [611] |
< 1999 | 40 | 103 | ELISA | [612] | |
Bangladesh | 1995 | 33 | 24 | LAT | [282] |
Brazil | < 1999 | 73 | 173 | IFAT | [557] |
Germany | 1989–90 | 66 | 61 | IFAT | [601] |
1989–90 | 58 | 88 | ELISA | [602] | |
1989–90 | 56 | 88 | IFAT | [602] | |
1992–94 | 59 | 112 | ELISA | [603] | |
1998 | 66 | 259 | ELISA | [613] | |
Italy | < 1997 | 33 | 490 | ELISA | [614] |
< 1997 | 33 | 490 | DAT | [614] | |
Japan | 1990–91 | 19 | 231 | LAT | [615] |
Korea | < 1999 | 13 | 198 | ELISA | [131] |
Singapore | < 1992 | 31 | 706 | LAT | [607] |
United Kingdom (Oxfordshire) | < 1996 | 62 | 45 | IHAT | [616] |
USA | |||||
Illinois | 1992–93 | 68 | 391 | MAT | [452] |
Iowa | < 1992 | 42 | 74 | MAT | [459] |
Turkey | < 1995 | 70 | 53 | IHAT | [617] |
Not classified | |||||
Argentina | 1988–94 | 61 | 145 | IFAT | [552] |
< 1997 | 35 | 55 | IFAT | [618] | |
Austria | < 1996 | 48 | 456 | IFAT | [114] |
Czech Republic | 1995–97 | 59 | 390 | IFAT | [619] |
Japan | 1989–91 | 11 | 726 | LAT | [620] |
Panama | 1990–92 | 32–61** | 141* | DAT | [155] |
Poland | 1992–96 | 71 | 357 | DAT | [621] |
Slovenia | < 1997 | 70 | 54 | IFAT | [622] |
< 1997 | 59 | 54 | ELISA | [622] | |
< 1997 | 57 | 54 | DAT | [622] | |
Turkey | < 1998 | 56 | 36 | SFDT | [623] |
< 1998 | 38 | 24 | SFDT | [624] | |
United Kingdom (Scotland) | < 1993 | 19* | 158 | – | [625] |
USA | < 1992 | 74 | 124 | ELISA | [626] |
Years of sampling are listed as published in the references. In cases where this information was not available, the year listed here is the year when the study was published, as indicated by ‘<’. Data from the 1980s are included if the study was published in the 1990s and if no recent data were available for the area.
Figures marked with ‘*’ were calculated from the published data. Seroprevalences marked with ‘**’ varied with the type of keeping or the year of examination.
DAT, direct agglutination test; ELISA, enzyme-linked immunosorbent assay; IFAT, indirect immunofluorescent antibody test; IHAT, indirect haemag-glutination test; LAT, latex agglutination test; MAT, modified agglutination test; SFDT, Sabin–Feldman dye test; –, not reported.